Yesterdays pr for me was further validation that Brilacidin is going to be a very valuable asset that will be monetized in the near future through a partnership or sale anybody's guess.
On a side note I noticed that Bio Tech Maven rare posts are deleted on the ILIE, a shame as he was a very sophisticated early B investor. Would have liked to hear his thoughts.
Anyway good things coming our way, will be adding.